Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas.


Journal

Experimental dermatology
ISSN: 1600-0625
Titre abrégé: Exp Dermatol
Pays: Denmark
ID NLM: 9301549

Informations de publication

Date de publication:
07 2019
Historique:
received: 01 02 2019
revised: 17 04 2019
accepted: 24 04 2019
pubmed: 30 4 2019
medline: 31 10 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

The association of clinical and dermoscopic features with BRAF mutational status has been poorly analysed in multiple primary melanomas (MPM). To investigate whether concordance of BRAF mutational status is associated with dermoscopic similarity in multiple melanomas of the same patient. Dermoscopic images and corresponding tissue sections of 124 melanomas from 62 patients with MPM were selected at four Italian Dermatology Departments. Similarity of dermoscopic appearance between multiple melanomas was evaluated according to the presence of the same prevalent dermoscopic feature. The BRAF A similar dermoscopic appearance was identified in 38.7% (24/62) of patients with MPM and was correlated with older age at first diagnosis (rho: 0.26; P: 0.042) and occurrence on sun-damaged skin (rho: 0.27; P: 0.037). The BRAF Dermoscopic similarity of multiple melanomas represents an independent clinical predictor of a concordant BRAF mutational status in MPM patients.

Sections du résumé

BACKGROUND
The association of clinical and dermoscopic features with BRAF mutational status has been poorly analysed in multiple primary melanomas (MPM).
OBJECTIVE
To investigate whether concordance of BRAF mutational status is associated with dermoscopic similarity in multiple melanomas of the same patient.
METHODS
Dermoscopic images and corresponding tissue sections of 124 melanomas from 62 patients with MPM were selected at four Italian Dermatology Departments. Similarity of dermoscopic appearance between multiple melanomas was evaluated according to the presence of the same prevalent dermoscopic feature. The BRAF
RESULTS
A similar dermoscopic appearance was identified in 38.7% (24/62) of patients with MPM and was correlated with older age at first diagnosis (rho: 0.26; P: 0.042) and occurrence on sun-damaged skin (rho: 0.27; P: 0.037). The BRAF
CONCLUSION
Dermoscopic similarity of multiple melanomas represents an independent clinical predictor of a concordant BRAF mutational status in MPM patients.

Identifiants

pubmed: 31034104
doi: 10.1111/exd.13951
doi:

Substances chimiques

BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

829-835

Subventions

Organisme : Italian Ministry of Health
ID : NET-2011- 02347213
Pays : International

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Elvira Moscarella (E)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Cristina Pellegrini (C)

Department of Dermatology, University of L'Aquila, L'Aquila, Italy.

Riccardo Pampena (R)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Giuseppe Argenziano (G)

Dermatology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.

Marco Manfredini (M)

Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.

Claudia Martorelli (C)

Department of Dermatology, University of L'Aquila, L'Aquila, Italy.

Alessia Ciarrocchi (A)

Laboratory of Translational Research, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Emi Dika (E)

Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

Ketty Peris (K)

Institute of Dermatology, Catholic University, Rome, Italy.

Ambra Antonini (A)

Department of Dermatology, University of L'Aquila, L'Aquila, Italy.

Gianluca Cipolloni (G)

Department of Pathology, San Salvatore Hospital, L'Aquila, Italy.

Roberto Alfano (R)

Department of Anesthesiology, Surgery and Emergency, Second University of Naples, Naples, Italy.

Caterina Longo (C)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.

Maria Concetta Fargnoli (MC)

Department of Dermatology, University of L'Aquila, L'Aquila, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH